| IAa (n = 40) | EAb (n = 77) | p-value |
---|---|---|---|
Medium follow-up (months) | 35.4 ± 8.9 | 40.2 ± 16.1 | 0.068 |
Recurrence, n (%) | 1 (2.5) | 7 (9.1) | 0.18 |
Liver | 0 (0) | 5 (6.5) | 0.1 |
Lung | 0 (2) | 2 (2.6) | 0.304 |
Carcinomatosis | 1 (2.5) | 3 (3.9) | 0.693 |
Death, n (%) | 2 (5) | 5 (6.5) | 0.747 |
2-year disease-free survival (%) | 97.5 | 90.9 | 0.182 |
Survival (%) | 38 (95) | 72 (93.5) | 0.747 |